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Transcriptomic evidence for 
modulation of host inflammatory 
responses during febrile 
Plasmodium falciparum malaria
Tuan M. Tran1,2, Marcus B. Jones3, Aissata Ongoiba4, Else M. Bijker5, Remko Schats6, 
Pratap Venepally3, Jeff Skinner1, Safiatou Doumbo4, Edwin Quinten6, Leo G. Visser6, 
Elizabeth Whalen7, Scott Presnell7, Elise M. O’Connell8, Kassoum Kayentao4, 
Ogobara K. Doumbo4, Damien Chaussabel7,9, Hernan Lorenzi10, Thomas B. Nutman8,  
Tom H. M. Ottenhoff6, Mariëlle C. Haks6, Boubacar Traore4, Ewen F. Kirkness3, 
Robert W. Sauerwein5 & Peter D. Crompton1
Identifying molecular predictors and mechanisms of malaria disease is important for understanding how 
Plasmodium falciparum malaria is controlled. Transcriptomic studies in humans have so far been limited 
to retrospective analysis of blood samples from clinical cases. In this prospective, proof-of-principle 
study, we compared whole-blood RNA-seq profiles at pre-and post-infection time points from Malian 
adults who were either asymptomatic (n = 5) or febrile (n = 3) during their first seasonal PCR-positive  
P. falciparum infection with those from malaria-naïve Dutch adults after a single controlled human 
malaria infection (n = 5). Our data show a graded activation of pathways downstream of pro-
inflammatory cytokines, with the highest activation in malaria-naïve Dutch individuals and significantly 
reduced activation in malaria-experienced Malians. Newly febrile and asymptomatic infections in 
Malians were statistically indistinguishable except for genes activated by pro-inflammatory cytokines. 
The combined data provide a molecular basis for the development of a pyrogenic threshold as 
individuals acquire immunity to clinical malaria.
Malaria is a significant public health burden caused by parasites of the genus Plasmodium, afflicting ~200 million 
people globally per annum1. Of the five species known to cause disease in humans, Plasmodium falciparum is 
responsible for the majority of malaria-related mortality. Plasmodium infection in the host liver is an asympto-
matic process but quickly progresses to the blood stage, during which the merozoite form of the parasite invades 
and replicates within erythrocytes. In non-immune individuals, it is the cyclical rupture of infected erythrocytes 
and release of daughter merozoites during blood-stage infection that coincides with the paroxysms of fever and 
chills typical of clinical malaria.
Although the role of antibodies in controlling both parasite density and the symptoms of malaria is well 
established2,3, less is known about the contribution of cellular immune responses to host resistance to malaria 
symptoms during blood-stage infection4. We previously reported that recent malaria exposure can dampen sub-
sequent P. falciparum-induced inflammation via a regulatory state mediated in part by the anti-inflammatory 
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cytokine IL-10 produced by CD4+CD25+Foxp3- T cells that also produce IFNγ and TNF5. This is consistent 
with other studies implicating IL-10 production by polyfunctional CD4+ T cells in the modulation of malaria 
severity6,7. A recent report also demonstrated that tolerance to malaria disease in children with a history of 
heavy malaria exposure is associated with the loss and dysfunction of Vδ 2+γ δ T cells, which normally produce 
pro-inflammatory cytokines in response to infection8. These studies have provided valuable insight on how toler-
ance to malarial disease may be conferred, primarily by measuring host modulation of inflammation in vitro using 
parasite-stimulated peripheral blood mononuclear cells obtained from individuals with varying degrees of prior 
malaria exposure. Ex vivo transcriptional profiling of peripheral blood cells has provided broader and more direct 
insight into cellular immune responses to natural Plasmodium blood-stage infections in malaria-experienced 
individuals5,9–13 and during controlled human malaria infections (CHMI)10,14. The over-arching theme of these 
transcriptomic studies is that interferon- and toll-like-receptor-mediated inflammatory signaling and antigen 
presentation pathways predominate during blood-stage infections, with significant T-cell activation occurring 
in malaria-experienced individuals during acute malaria. However, these studies were limited to the analysis of 
individuals who were susceptible to clinical malaria and were not designed to prospectively identify molecular 
predictors and mechanisms of clinical immunity to P. falciparum.
We recently conducted a prospective cohort study of malaria-experienced individuals in Kalifabougou, Mali 
during which we collected blood samples by finger prick every 2 weeks and determined by PCR when each indi-
vidual’s first P. falciparum infection of the malaria season occurred15, thereby allowing us to compare changes 
in immune responses before and during incident infections that did or did not progress to febrile malaria. Here, 
in a proof-of-principle study, we performed whole-blood RNA-seq of fingerprick blood samples collected from 
Malian adults who were either asymptomatic or febrile at the time of their first P. falciparum infection of the 
malaria season and compared these gene-expression profiles to those of previously malaria-naïve adults who 
were infected with P. falciparum in a CHMI study16. We provide evidence for disease tolerance to malaria at the 
transcriptome level, demonstrating that malaria-experienced individuals dampen P. falciparum-induced inter-
feron and inflammatory responses during acute infection despite having higher parasite densities than naïve 
individuals.
Results
Study participant characteristics. Thirteen subjects, each with paired samples collected at their P. falciparum 
PCR-negative, uninfected baseline and during their incident, P. falciparum PCR-detectable blood-stage infec-
tion, were included in the group RNA-seq analyses (Fig. 1; Table 1). Eight subjects were from the Malian study, 
of whom 3 were febrile with uncomplicated malaria at incident infection (malaria-experienced, febrile; EF) and 
5 were asymptomatic at incident infection (malaria-experienced, asymptomatic; EA). Of note, 2 individuals in 
the EA class progressed to febrile malaria within 5 days of initial PCR-detectable blood-stage infection, whereas 
the other 3 individuals carried their infections without symptoms throughout the rest of the 6-month malaria 
season. However, because we detected no differentially expressed genes (DEGs) between individuals in the EA 
class who progressed to fever and individuals in the EA class who remained asymptomatic, all 5 subjects in the 
EA class were analyzed as a single group. Five subjects were previously malaria-naïve individuals from the CHMI 
study who experienced uncomplicated febrile malaria after a single CHMI (malaria-naïve, febrile; NF). NF sub-
jects were all women, and EF subjects were slightly younger (mean age 16.0 years; range 13.5–18.3) than subjects 
in classes EA (19.7 years; 15.3–23.3) and NF (20.6 years; 19.0–22.0) (Table 1). Haemoglobin levels at uninfected 
baseline were comparable between classes. At the incident infection, axillary temperatures for classes NF (mean 
38.5 °C; range 37.7–39.4) and EF (38.5 °C; 37.7–39.4) were similar, and both were higher than class EA (36.5 °C; 
36.1–37.2). Parasite densities at incident infection were lowest in class NF and highest in class EF (Table 1). All 
Malian individuals had a normal haemoglobin genotype AA (HbAA) except for one HbAC individual in the EF 
class. At the uninfected baseline, no Malian individuals were infected with Schistosoma mansoni by the Kato-
Katz technique or with Necator americanus, Ancylostoma duodenale, Trichuris trichiura, Ascaris lumbricoides, or 
Strongyloides stercoralis by real-time PCR of stool genomic DNA (gDNA). Among the 6 Malians for whom urine 
samples were available, none were positive for Schistosoma haematobium by microscopy. No Malian individuals 
were infected by the bloodborne filarial nematode Mansonella perstans by PCR of blood gDNA at either the unin-
fected baseline or the first P. falciparum infection of the malaria season.
Generation of RNA-seq data. The average number of mapped reads per sample was 71 million paired-end 
reads with a range of 24 to 130 million paired-end reads (Supplementary Data S1). Using a human exome size of 
~50 Mb17 and the number of ~100 bp reads that mapped to the human genome per sample, the estimated range of 
coverage among our samples was 14X to 81X (Supplementary Data S1).
Correlation of genome-wide expression across samples. Genome-wide expression of whole blood 
was performed using RNA-seq for paired uninfected and infected samples for all individuals (26 samples total). 
Hierarchical clustering of the transcriptome correlation matrix of all samples, after removal of site-specific batch 
effects, segregated individuals into 2 major clusters defined by P. falciparum infection status, regardless of whether 
the top 50% or the top 10% most variably expressed genes were used (Supplementary Fig. S1). Interestingly, 
within the uninfected cluster, individuals tended to cluster by class.
Differential gene expression during incident P. falciparum infection. To determine the differences 
in gene transcription induced by incident P. falciparum infection between malaria-naïve and malaria-experienced 
individuals with and without disease, we employed RNA-seq analysis of uninfected/infected sample pairs in a 
multifactorial design to account for intra-individual variation and enhance statistical power18 (Supplementary 
Data S2–S7). The majority of malaria-experienced individuals responded to P. falciparum infection more 
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similarly to each other than to malaria-naïve individuals irrespective of febrile symptoms by both principal com-
ponent analysis (PCA) and hierarchical cluster analysis using the top 50% (8208) most variably expressed genes 
(Fig. 2a,b). Despite significantly lower parasitemia (Table 1), incident infection resulted in a comparable number 
of transcriptional changes within the Δ NF class (2812 DEGs using an absolute fold-change threshold of > 1.5 and 
false discovery rate [FDR] < 0.05) relative to the Δ EF class (2725 DEGs), with 1296 DEGs shared between the 
two comparisons (Fig. 2c). At these fold-change and significance thresholds, no DEGs were observed for Δ EA 
(Fig. 2c). The Δ NF vs. Δ EA between-class comparison had the largest number of DEGs (1106 genes), of which 
303 overlapped with the Δ NF vs. Δ EF comparison (Fig. 2d; Supplementary Data S5 and S6). The between-class 
Δ EF vs. Δ EA comparison revealed only 70 DEGs using our pre-set thresholds (Fig. 2d; Supplementary Data S7), 
despite the apparent clinical differences and large differences in the number of within-class DEGs for these two 
classes.
Figure 1. Study design and classes. RNA-seq was performed on whole blood collected prior to infection and at 
the first PCR-detectable P. falciparum (Pf) blood-stage infection in a natural malaria infection study of malaria-
experienced individuals or during a controlled human malaria infection study of naïve individuals as described 
in the Methods.
EA EF NF P value
Number 5 3 5
% Female 40 66.7 100 NSa
Mean age in years (range) 19.7 (15.3–23.3) 16.0 (13.5–18.3) 20.6 (19.0–22.0) NSb
Mean hemoglobin (g/dL) at 
uninfected baseline (range) 14.1 (12.1–17.6) 13.2 (12.6–13.6) 13.1 (12.4–14.3) NS
b
Mean temperature (°C) at first 
infection (range) 36.5 (36.1–37.2) 38.5 (37.7–39.4) 38.5 (37.7–39.4) NA
Mean parasite density (parasites/μ l) 
at first infection (range) 5100 (1000–8100) 22,000 (14,000–31,000) 57 (4.1–100) 0.0051
b
Table 1.  Participant Characteristics. Abbreviations: EA, malaria-experienced, asymptomatic at first infection; 
NF, naïve, asymptomatic at first infection; EF, malaria-experienced, febrile at first infection; NS, not significant; 
NA, not applicable. aFisher’s exact test. bKruskal-Wallis test.
www.nature.com/scientificreports/
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Biological pathways affected during acute P. falciparum infection. To identify the biological path-
ways associated with P. falciparum infection in naïve and malaria-experienced individuals, we determined the 
overlap between the DEGs determined within each of the Δ NF and Δ EF classes (FDR < 0.05, no fold change 
filter) and Ingenuity canonical pathways by Fisher’s exact test. Using a cut-off of P < 0.05 (adjusted for multiple 
comparisons using the Benjamini-Hochberg method), acute febrile malaria significantly affected 196 pathways 
in the Δ NF class and 198 pathways in the Δ EF class (Supplementary Data S8 and S9), with the most significantly 
activated pathway being interferon signalling in the Δ NF class (Fig. 3a) and B-cell receptor signalling in the 
Δ EF class (Fig. 3b). Although several significantly overrepresented immune and inflammatory pathways appear 
in both the Δ NF and Δ EF comparisons, such as NFκ B signalling and immune-related apoptosis, there tended to 
be higher ranking of adaptive immunity pathways (i.e. B and T cell-related signalling) in the Δ EF class relative to 
the Δ NF class (Fig. 3a,b).
Predicted upstream regulators induced by acute P. falciparum infection. To determine which 
molecules might be important in the regulation of malaria immunity, we applied DEGs with a FDR < 0.05 
(no fold change filter) from each of the 6 contrasts outlined in the Methods (Supplementary Data S2–S7) to 
Ingenuity’s upstream regulator analysis to determine genes that are predicted to be important regulators during 
P. falciparum infection. Using an absolute z-score of > 2 and P value < 0.01 as the cut-off for significance, both 
Type I/II interferon, innate immunity, and pro-inflammatory genes were predicted to be highly activated in both 
the Δ NF and Δ EF classes, with IFNG and IRF7 having the strongest activation scores (Fig. 4a,b). Overall, genes 
Figure 2. Whole-blood transcriptomic analysis of paired uninfected and infected samples demonstrates 
greater gene expression changes in NF than EF individuals during febrile malaria. Clinical classes were 
defined as in Fig. 1, and characteristics of subjects used in this analysis are in Table 1. (a) Principal component 
analysis of the paired RNA-seq samples (infected – uninfected baseline samples for each subject) using the top 
50% most variably expressed genes across all paired samples after normalization of raw data (n = 13 subjects). 
(b) An unsupervised clustering heat map (Spearman correlation with Ward’s linkage) of the top 50% most 
variably expressed genes (8208 genes). Red intensity indicates increased expression with infection, and blue 
intensity indicates decreased expression with infection. Clinical classes are denoted as blue (NF), red (EF), 
and gray (EA). Female gender is denoted as black. Grayscale intensities represent relative rankings for age, 
temperature, and parasite density. Differential gene expression analysis for paired infection vs. uninfected 
baseline comparisons within each clinical class (c) and between each class (d) using contrasts described in the 
Methods. Venn diagrams show the number of differentially expressed genes (DEGs) using an absolute log2 
fold-change (logFC) of > 0.585 (1.5-fold in linear space) and a false discovery rate (FDR) < 0.05. For the smear 
density plots, the average expression in log counts per million (x axis) is plotted against logFC (y axis), DEGs 
with FDR < 0.05 are visualized as red points, and the fold-change cut-off is represented as blue lines.
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related to innate immunity and inflammation were predicted to be activated to a greater degree in the Δ NF 
compared to the Δ EF class (Fig. 4c). IL1RN, MAPK1, TRIM24 and NKX2-3 were inhibited during infection in 
both classes, with significantly more inhibition in the Δ NF class relative to the Δ EF class (Fig. 4c). Although no 
DEGs were observed for the asymptomatically infected Δ EA class even at more relaxed cut-offs, we were still 
able to assess the relative differences in response to infection between this class and the Δ NF and Δ EF classes 
using the between-class contrasts. During acute infection, 98 genes were predicted to be differentially regulated 
between the Δ NF and Δ EA classes, with significantly stronger activation of pro-inflammatory (e.g. TNF, IL1B, 
RELA, NFKB1A) and interferon-related genes (IFNG, IRF7, IFNA2, IFNL1) in the Δ NF class (Fig. 4d; only top 
40 regulators shown). The two malaria-experienced classes Δ EF and Δ EA differed in predicted regulation for 24 
genes, 10 of which were inflammatory genes predicted to be activated in the Δ EF class relative to the Δ EA class, 
when DEGs with a FDR threshold of < 0.10 was applied (Fig. 4d). Interestingly, among the genes predicted to be 
differentially activated in the Δ EF class relative to the Δ EA class are those known to encode for the endogenous 
pyrogens TNF, IFN-γ and IL-1β .
Changes in modular transcriptional repertoire during acute P. falciparum infection. We used 
modular transcriptional repertoire analysis19 to determine the overall expression of DEGs that overlapped with 
modules of co-dependent gene sets known to be associated with specific cellular functions and cell subsets within 
each class (Fig. 5a) or between classes (Fig. 5b) during acute P. falciparum infection. Consistent with pathways 
and upstream regulator analyses, the Δ NF class had greater overexpression of interferon modules (M1.2, M3.4, 
M5.12) than the Δ EF and Δ EA classes (Fig. 5a,b). Differences in inflammation between the Δ NF and Δ EF 
classes were less consistent, with comparable overexpression in some inflammation modules (M4.6, M5.1, and 
M7.22) and decreased overexpression in Δ NF in others (M3.2, M4.2, M4.13; Fig. 5a,b). For the cell subset reper-
toires, overexpression of the monocyte module (M4.14) and underexpression of the B and T cell modules (M4.1, 
M4.10, M4.15, and M9.2) were seen during acute infection in both classes, in keeping with the peripheral blood 
monocytosis and lymphopenia commonly observed during acute malaria episodes in both semi-immune and 
naïve individuals during natural infection20 and CHMI21, respectively. Of note, acute malaria induced expression 
of genes in the erythrocyte (M2.3, M3.1, M6.18) and platelet (M1.1) modules in the Δ NF class to a greater extent 
than Δ EF class, (Fig. 5a), which could be due to reticulocytosis and increases in immature platelet fraction during 
CHMI22.
Discussion
Here, we used RNA-seq to evaluate changes from pre-infection baseline in whole-blood transcription profiles dur-
ing both febrile and asymptomatic natural P. falciparum infections in malaria-experienced Malian adults and com-
pared these values to transcriptional changes in malaria-naïve Dutch adults who experienced fever after CHMI. 
Figure 3. Molecular signatures of febrile malaria in naïve and malaria-experienced individuals differ in 
intensity and quality by pathways analysis. Canonical pathways analysis using DEGs with FDR < 0.05 (no 
fold-change cut-off) for the Δ NF (a) and Δ EF (b) classes.
www.nature.com/scientificreports/
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Figure 4. Upstream regulator analysis reveals graded activation of interferon-mediated inflammation. Upstream 
regulator analysis using the DEGs with FDR < 0.05 (no fold-change cut-off) for the Δ NF (a) and Δ EF (b) classes. 
A positive z-score predicts activation of the indicated gene based on the expression patterns of downstream genes, 
whereas a negative z-score predicts inhibition. (c) Z-score data from (a,b) in heatmap format is shown with the 
addition of z-scores from the between group (Δ NF-Δ EF) analysis. Rows are sorted by descending Z-scores in the 
third column. (d) Z–scores in heatmap format for between-class comparisons of Δ NF and Δ EF with Δ EA using 
DEGS with FDR < 0.10 (no fold-change cut-off). Rows are sorted by descending Z-scores in the second column.  
Only the top 40 predicted regulators with an absolute z-score > 2 and P value < 0.01 are shown.
www.nature.com/scientificreports/
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We took advantage of the prospective design of a time-to-infection study in Kalifabougou, Mali and a CHMI study 
and used paired-sample analysis in order to eliminate baseline noise due to inter-individual variation.
Using pathways, upstream regulator and modular transcriptional analysis, we show that robust transcriptional 
changes during febrile malaria translated into striking quantitative and qualitative differences in the immuno-
logical response between naïve and malaria-experienced individuals, with naïve individuals having a dominant 
interferon-mediated, pro-inflammatory response likely driven by dendritic cells and monocytes as suggested 
by the modular transcriptional analysis. Despite having 300X higher parasite densities at the time of diagnosis, 
malaria-experienced individuals exhibited a dampened interferon-driven inflammatory response relative to naïve 
individuals during febrile infection, suggesting disease tolerance, but also enhanced B-cell receptor signalling not 
evident in naïve individuals, suggesting more robust adaptive immunity. The shorter time-to-diagnosis within the 
NF class due to daily monitoring for the CHMI study is unlikely to account for this difference, as it seems unlikely 
that a malaria-naïve individual would become more tolerant of symptoms as parasite densities increase to levels 
comparable to those in the EF class. Likewise, the asymptomatic EA class, which presented to clinic with 100X 
higher parasite densities than the NF class, provides evidence of variable disease tolerance in malaria-experienced 
individuals, with some individuals progressing to febrile malaria within 5 days of incident blood-stage infection, 
whereas the others carried their infections through the rest of the malaria season without symptoms.
Our data suggest a graded activation of pathways downstream of the pro-inflammatory cytokines IFNγ , TNF, 
and IL-1β that is associated with prior malaria-exposure, with naïve individuals having the greatest activation 
and malaria-experienced asymptomatic individuals having the least. This stands in contrast with a study by 
Figure 5. Modular transcriptional repertoire analysis shows differential induction of functional and cell subset 
modules in naïve and malaria-experienced individuals during febrile malaria. Modular transcriptional repertoire 
analyses using DEGs with FDR < 0.05 (no fold-change cut-off) for within class (a) and with FDR < 0.10 (no fold-
change cut-off) for between class (b) comparisons. Only modules with differences in at least one comparison are 
shown. Rows are clustered by Euclidean distance with Ward’s linkage.
www.nature.com/scientificreports/
8Scientific RepoRts | 6:31291 | DOI: 10.1038/srep31291
Ockenhouse et al. which compared transcriptomic changes in PBMCs collected during CHMI in naïve indi-
viduals at early blood-stage infection with that of malaria-experienced adults experiencing naturally acquired 
febrile malaria and found similar induction in pro-inflammatory cytokines IFNγ , TNF, and IL-1β between 
pre-symptomatic and symptomatic individuals regardless of prior malaria exposure history10. The likely expla-
nation is that whereas all naïve individuals had febrile malaria (temperature > 37.5) in our study, the majority of 
experimentally infected naïve individuals in Ockenhouse et al. were pre-symptomatic and therefore would not be 
expected to have as robust an inflammatory response as previously naïve individuals experiencing febrile malaria. 
A recent RNA-seq study of naïve and malaria-experienced Colombian volunteers who underwent CHMI with 
P. vivax also found no differential response in the fever-inducing inflammatory cytokines IL-1β , IL-6, IL-8 and 
TNF between naïve and malaria-experienced individuals at the time of diagnosis14. Aside from being a study on 
P. vivax, malaria-experienced subjects also had variable symptomatology at the time of diagnosis, as a majority of 
individuals did not exhibit fever23, making it difficult to make direct comparisons to our study, which separated 
malaria-experienced individuals into those with and without fever during incident P. falciparum infection.
An alternative explanation for the dampened inflammatory response observed in Malians versus Dutch indi-
viduals may be exposure to endemic helminths, which can protect individuals from febrile malaria24. Despite 
having no evidence of such infections at enrolment, modulated inflammation due to prior helminth exposure or 
co-infection with intestinal helminths during incident P. falciparum infection in the Malian individuals remains 
a possibility. Although we cannot completely exclude differences in ethnic or genetic background as potential 
confounders, none of the Malian individuals carried the malaria-protective sickle cell trait25, and none iden-
tified themselves as being from the Fulani ethnic group, which is known to be more protected from clinical 
malaria than other sympatric ethnic groups in West Africa26. Technical bias due to RNA-processing differences 
between Malian and Dutch samples is an unlikely explanation for our findings given the stable expression of 
non-inflammatory genes, including previously validated endogenous controls, across all samples (Supplementary 
Fig. S2) and the paired analysis of samples.
Despite using a paired design to enhance statistical power, small class sizes limited our ability to detect tran-
scriptional changes during asymptomatic infections (i.e. ∆ EA class), which are expected to induce more modest 
gene expression. Other possible reasons include the 2-week resolution for active surveillance for P. falciparum 
infection by PCR that may have missed the peak host response to initial blood-stage infection, or heterogeneity 
in disease tolerance within the asymptomatic group.
Although no significant changes were detected in the ∆ EA comparison, 2725 DEGs were detected in 
the ∆ EF comparison, implying robust differences in P. falciparum-induced gene expression between the 
malaria-experienced classes. Yet, direct comparison of ∆ EF vs. ∆ EA revealed only 70 DEGs using the same sig-
nificance thresholds. Inspection of the top DEGs within the ∆ EA class with an unadjusted P value < 0.05 provides 
some explanation for this discrepancy (Supplementary Data S2). These top ∆ EA genes are involved in similar 
inflammatory and innate pathways induced during febrile malaria (Supplementary Fig. S3) to an extent that 
might influence the between-class analyses without satisfying the threshold of FDR < 5% in the within-class ∆ EA 
analysis. Indeed, the ∆ EF and ∆ EA classes were statistically indistinguishable from each other except for genes 
that are predicted to be regulated by TNF, IFNγ , IL-1β , which are the precise cytokines responsible for the clinical 
feature that differentiates the two classes: fever (Fig. 4d). Given the power limitations of our study, genes within 
these innate, inflammatory pathways likely reflect the largest transcriptional changes between asymptomatic and 
febrile P. falciparum infections in malaria-experienced classes. Importantly, these findings relied on the coordi-
nated expression of known targets of transcriptional regulators and the overlap with pre-defined gene sets rather 
than a few isolated genes, thus reducing the likelihood of a false discovery.
The presence of a batch effect related to study-site precluded any meaningful differential gene expression 
(DGE) analysis between classes using only pre-infection baseline data, as the NF class and Dutch study site were 
synonymous. Interestingly, removal of study-site batch effects, which also removes biological variation, still 
resulted in higher within-class correlations than between-class correlations among pre-infection baseline tran-
scriptomes, a finding that could be reflective of either the disparate genetic and/or environmental backgrounds 
between classes and/or differences in prior malaria-exposure. Although this observation requires evaluation in a 
larger study, the notion that pre-infection cellular signatures can predict host responses during blood-stage infec-
tion is compelling, given recent evidence that pre-perturbation cell populations can predict antibody responses 
induced by influenza vaccination27.
Dual host-pathogen RNA-seq has previously been used to investigate interactions between the human and 
P. falciparum transcriptomes using whole blood obtained during acute malaria13. As expected, we found a posi-
tive correlation between parasite density and P. falciparum-specific read counts, but the low-density infections in 
both the NF and EA classes precluded us from obtaining sufficient P. falciparum read counts in these samples for 
DGE analysis with the EF class. Future attempts at dual RNA-seq with low-density infections will likely require 
isolation of host and parasite genetic material prior to RNA collection.
In summary, we provide transcriptomic evidence of disease tolerance in human malaria, demonstrating reg-
ulated interferon-mediated inflammatory responses in malaria-experienced individuals during P. falciparum 
blood-stage infections that would otherwise induce intense inflammation in naïve individuals at much lower 
parasite densities. Differences in the molecular intensity of febrile malaria are accompanied by qualitative differ-
ences, with prominent activation of B-cell receptor signalling that is unique to malaria-experienced individuals. 
Taken together, these data provide a molecular basis for the development of a pyrogenic threshold as individuals 
acquire natural immunity to malaria disease. Larger studies are needed to validate these findings and to gain fur-
ther insight into the cellular immune response during asymptomatic Plasmodium infections.
www.nature.com/scientificreports/
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Methods
Ethics Approval. Written informed consent was obtained from all subjects. The Malian cohort study was 
approved by the Ethics Committee of the Faculty of Medicine, Pharmacy and Dentistry at the University of 
Sciences, Technique and Technology of Bamako and the Institutional Review Board of the National Institute of 
Allergy and Infectious Diseases, National Institutes of Health. The study in Mali is registered on http://www.clin-
icaltrials.gov (NCT01322581). The CHMI study was approved by the Central Committee for Research Involving 
Human Subjects of The Netherlands (NL33904.091.10) and complied with the Declaration of Helsinki and Good 
Clinical Practice.
Malian Study Site, Study Population and Sample Collection. The malaria-experienced individuals 
for this study are part of a larger on-going prospective cohort study of naturally acquired malaria immunity15,24. 
Briefly, the study was conducted in Kalifabougou, Mali, where P. falciparum malaria transmission is intense 
and seasonal, occurring from June through December15. In May 2011, we enrolled 695 healthy children and 
adults, aged 3 months to 25 years, into a longitudinal observational cohort study to investigate malaria immunity 
in which we conducted bi-weekly active surveillance for Plasmodium infection and weekly active and passive 
surveillance for clinical malaria. Exclusion criteria included a haemoglobin level < 7 g/dL, axillary temperature 
≥ 37.5 °C, acute systemic illness, underlying chronic disease, use of antimalarial or immunosuppressive medi-
cations in the past 30 days, or pregnancy. Haemoglobin typing for HbS and HbC was performed with a D-10 
instrument (Bio-Rad). Malaria episodes were pre-defined as parasitaemia of ≥ 2500 parasites/μ L, an axillary tem-
perature of ≥ 37.5 °C within 24 hours, and no other cause of fever discernible by physical exam. By finger prick 
we collected whole-blood for RNA (200 μ l whole blood in 400 μ l of Tempus solution [Applied Biosystems]), dried 
blood spots (DBS) on filter paper (Protein Saver 903, Whatman), cell pellets, and plasma from healthy, unin-
fected children and adults at enrolment (before the 6-month malaria season), during bi-weekly scheduled visits, 
and at their first malaria episode of the ensuing transmission season. After transport from the field site, RNA, 
blood pellets, and plasma were stored at − 80C until analysis. Point-of-care blood smears were performed for 
individuals symptomatic at any clinic visit, with anti-malarials given for any Plasmodium positive smears per the 
Malian national guidelines. For each subject, the first P. falciparum infection of the malaria season was detected 
retrospectively by PCR analysis of the longitudinally collected DBS15, and positive samples were then quantified 
by qPCR28. First malaria episodes were determined from the clinical visit data.
Here, we focus on individuals > 13 years old, which is the age when levels of P. falciparum-specific antibodies 
approach adult-like levels in this cohort29. From this subset, we randomly selected 1) individuals who were febrile 
at the time of their first PCR-detected P. falciparum infection (malaria-experienced, febrile; EF) and 2) individu-
als who were asymptomatic at the time of their first PCR-detected P. falciparum infection (malaria-experienced, 
asymptomatic; EA) for whom samples were available for RNA-seq.
Screening for helminth co-infections in Malian subjects. Screening for helminths at uninfected base-
line (enrolment) was performed as previously described24. Briefly, urine was assessed for Schistosoma haematobium 
eggs by microscopy after urine filtration. Presence of Schistosoma mansoni eggs was assessed by microscopy of stool 
using the Kato-Katz technique30. The intestinal nematodes Necator americanus, Ancylostoma duodenale, Trichuris 
trichiura, Ascaris lumbricoides, and Strongyloides stercoralis were detected following DNA extraction from stool31 
by multi-parallel, real-time PCR32. In addition, PCR-detection of the bloodborne filarial nematode Mansonella 
perstans was also performed on gDNA extracted at both the uninfected baseline and the first P. falciparum  
infection of the malaria season with two 3-mm DBS punches using an established protocol33.
Controlled human malaria infections. The malaria-naïve individuals in this study, all of whom were 
febrile during P. falciparum infection (malaria-naïve, febrile; NF) included five individuals who were recruited 
as infectivity controls for a previously described CHMI study (NCT01218893)16. Briefly, all five individ-
uals tested negative for P. falciparum-specific antibodies by ELISA at enrolment, and none had travelled to a 
malaria-endemic area within 6 months prior to the study. In October 2011, individuals were challenged simulta-
neously by exposure to bites of five Anopheles stephensi mosquitoes infected with the NF54 P. falciparum strain 
and monitored by daily thick blood smear starting on days 5–6 post-challenge. Whole blood was collected for 
RNA in PAXgene blood RNA tubes (PreAnalytiX) on the day prior to challenge; days 5, 6 and 9 after challenge; 
the day of treatment; and day 35 after challenge. In addition to blood-smear diagnosis, parasite density was also 
retrospectively quantified by qPCR of blood DNA samples collected up to twice daily from day 5 until day 21 after 
challenge to determine the time to PCR-positivity as described previously16. Curative anti-malarial treatment 
with atovaquone/proguanil was provided immediately after patent parasitaemia was detected.
Generation of RNA-seq data. For all Dutch samples, total RNA was extracted from whole blood using 
the PAXgene Blood miRNA Kit (Qiagen). RNA was converted to cDNA and amplified using Ovation RNA-Seq 
System V2 (Nugen), which uses single-primer isothermal amplification equivalent to 12 cycles of PCR ampli-
fication, and library preparation was performed with the TruSeq Nano Kit (Illumina) per the manufacturers’ 
instructions. For the Malian samples, total RNA was extracted from whole blood using the Tempus Spin RNA 
isolation kit (Thermo Fisher) and depleted of rRNA and globin RNA before amplification using the ScriptSeq 
Complete Gold Kit (Illumina). Directional RNA-seq libraries were prepared using the ScriptSeq v2 kit with bar-
code adapters (Epicentre), which includes a 15-cycles of PCR amplification. For both Malian and Dutch sam-
ples, sequencing of 2 × 100 bp paired-end reads was performed on a HiSeq 2000 using V3 reagents (Illumina). 
The Illumina sequences were trimmed of bases with a Phred quality score of less than 15 and any contaminat-
ing adapters used in the preparation of cDNA and sequencing libraries by the Trimmomatic program34. Only 
paired-end reads which survived trimming and were ≥ 60 bases in length were mapped to the human (GRCh37, 
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version 17, Ensembl 72) and Plasmodium falciparum 3D7 (version 3 annotation, Dec 2012) genomes in parallel 
using TopHat2 35. Transcript abundance was determined by Cufflinks36. Although samples from the Malian and 
Dutch studies were processed and sequenced at separate times, paired samples from the same subject were always 
processed together. Sequencing data is available on the Gene Expression Omnibus (GEO) database under the 
accession numbers GSE52166 (natural infection) and GSE50957 (CHMI).
Gene expression analysis. Gene expression analysis of RNA-seq read counts mapping to the human 
genome was performed using edgeR (version 3.10.2)37. Filtering and normalization were performed for unin-
fected and infected samples simultaneously prior to downstream paired analyses. After removal of genes on the 
Y chromosome, TMM normalization was applied, followed by removal of low-expression genes (genes with < 1 
count per million [CPM] in ≥ 10% of the samples). To verify that RNA processing differences in the Malian and 
Dutch samples did not produce a technical bias in genome-wide expression levels, we evaluated expression of 16 
genes previously identified as being stable endogenous controls across a panel of human tissues38 and in human 
whole blood across multiple disease states39 and found their expression to be comparable between Malian and 
Dutch samples (Supplementary Fig. S2).
Expression data for the top 50% most variable genes by median absolute deviation40 were converted to log-
CPM, and unwanted variation (i.e. study site-specific batch effects) were removed using the remove BatchEffect 
function in the limma package prior to generation of correlation matrices, PCA plots and unsupervised hierar-
chical clustering heatmaps. For data visualization in the paired analysis, logCPMinfected − logCPMuninfected (delta 
logCPM) values were used for each subject. We compared the effect of infection within subjects as well as the dif-
ferences between classes while taking into account the pairing of samples by subject. We used the following model 
formula which has class as the main effect with nested interactions for subject and infection status: ~Class + 
Class:Subject + Class:Infection. Thus, differences in batch, sex, and age were accounted for by the subject effect, 
as each subject’s pre-infection baseline served as his or her own control. DGE analysis was performed by fitting 
counts for each gene to a negative binomial generalized log-linear model using the glmLRT function for the fol-
lowing within class comparisons, set up as contrasts:
− − −NF NF ; EF EF ; EA EAinfected uninfected infected uninfected infected uninfected
Between-class comparisons were also performed:
− − −(NF NF ) (EF EF );infected uninfected infected uninfected
− − −(NF NF ) (EA EA );infected uninfected infected uninfected
− − −(EF EF ) (EA EA )infected uninfected infected uninfected
Gene symbols, log-fold change ratios, unadjusted P values, and false discovery rates from results of the model 
were imported into Ingenuity Pathway Analysis (IPA, Qiagen) to determine pathway enrichment scores and per-
form upstream regulator analyses and into a custom R script for modular transcriptional repertoire analysis19,41.
Evaluation of P. falciparum-specific read counts. Our initial strategy of simultaneously mapping read 
counts to both human and P. falciparum reference genomes sought to determine relationships between the host 
and parasite transcriptomes in minimally processed finger prick whole blood samples, with the goal of compar-
ing parasite transcriptomes in both asymptomatic and febrile infections. Such a strategy yields sufficient human 
but not P. falciparum mapped counts, presumably due to the overwhelming abundance of human transcripts in 
whole blood un-enriched for parasite material, with adequate library sizes for P. falciparum only observed at high 
parasite densities (> 10,000 parasites/μ l; Supplementary Fig. S4).
Statistical analysis. Statistical analyses were performed in R 3.2.3 (https://cran.r-project.org) as indicated in 
the results or figure legends. Statistical significance was set at FDR < 0.05 unless noted otherwise.
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